• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低危甲状腺微小乳头状癌:主动监测试验的回顾。

Low-risk papillary microcarcinoma of the thyroid: A review of active surveillance trials.

机构信息

Department of Surgery, Kuma Hospital, Kobe 650-0011, Japan.

Department of Surgery, Kuma Hospital, Kobe 650-0011, Japan.

出版信息

Eur J Surg Oncol. 2018 Mar;44(3):307-315. doi: 10.1016/j.ejso.2017.03.004. Epub 2017 Mar 16.

DOI:10.1016/j.ejso.2017.03.004
PMID:28343733
Abstract

Papillary microcarcinoma (PMC) of the thyroid is defined as papillary thyroid carcinoma (PTC) measuring ≤1 cm. Many autopsy studies on subjects who died of non-thyroidal diseases reported latent small thyroid carcinoma in up to 5.2% of the subjects. A mass screening study for thyroid cancer in Japanese adult women detected small thyroid cancer in 3.5% of the examinees. This incidence was close to the incidence of latent thyroid cancer and more than 1000 times the prevalence of clinical thyroid cancer in Japanese women reported at that time. The question of whether it was correct to treat such PMCs surgically then arose. In 1993, according to Dr. Miyauchi's proposal, Kuma Hospital initiated an active surveillance trial for low-risk PMC as defined in the text. In 1995, Cancer Institute Hospital in Tokyo, Japan, started a similar observation trial. The accumulated data from the trials at these two institutions strongly suggest that active surveillance (i.e., observation without immediate surgery) can be the first-line management for low-risk PMC. Although our data showed that young age and pregnancy might be risk factors of disease progression, we think that these patients can also be candidates for active surveillance, because all of the patients who showed progression signs were treated successfully with a rescue surgery, and none of them died of PTC. In this review, we summarize the data regarding the active surveillance of low-risk PMC as support for physicians and institutions that are considering adopting this strategy.

摘要

甲状腺微小乳头状癌(PMC)被定义为直径≤1cm 的甲状腺乳头状癌(PTC)。许多关于死于非甲状腺疾病的患者的尸检研究报告称,高达 5.2%的患者存在潜在的小甲状腺癌。一项针对日本成年女性甲状腺癌的大规模筛查研究发现,3.5%的受检者患有小甲状腺癌。这一发病率与潜伏性甲状腺癌的发病率相近,是当时报告的日本女性临床甲状腺癌发病率的 1000 多倍。那么,是否应该对这些 PMC 进行手术治疗的问题就出现了。1993 年,根据宫内医生的建议,熊本医院启动了一项针对文中定义的低危 PMC 的主动监测试验。1995 年,日本东京癌症研究所也开始了类似的观察性试验。这两个机构的试验累积数据强烈表明,主动监测(即不立即手术的观察)可以作为低危 PMC 的一线治疗方法。虽然我们的数据显示,年轻和妊娠可能是疾病进展的危险因素,但我们认为这些患者也可以成为主动监测的候选者,因为所有出现进展迹象的患者都成功地接受了挽救性手术治疗,没有一例死于 PTC。在这篇综述中,我们总结了关于低危 PMC 主动监测的数据,为考虑采用这种策略的医生和机构提供支持。

相似文献

1
Low-risk papillary microcarcinoma of the thyroid: A review of active surveillance trials.低危甲状腺微小乳头状癌:主动监测试验的回顾。
Eur J Surg Oncol. 2018 Mar;44(3):307-315. doi: 10.1016/j.ejso.2017.03.004. Epub 2017 Mar 16.
2
Insights into the Management of Papillary Microcarcinoma of the Thyroid.甲状腺微小乳头状癌的处理要点。
Thyroid. 2018 Jan;28(1):23-31. doi: 10.1089/thy.2017.0227. Epub 2017 Sep 22.
3
A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma.在考虑对乳头状微小癌采用主动监测替代立即活检和手术时,用于促进风险分层的临床框架。
Thyroid. 2016 Jan;26(1):144-9. doi: 10.1089/thy.2015.0178. Epub 2015 Nov 5.
4
Clinical Trials of Active Surveillance of Papillary Microcarcinoma of the Thyroid.甲状腺乳头状微小癌主动监测的临床试验
World J Surg. 2016 Mar;40(3):516-22. doi: 10.1007/s00268-015-3392-y.
5
Incidences of Unfavorable Events in the Management of Low-Risk Papillary Microcarcinoma of the Thyroid by Active Surveillance Versus Immediate Surgery.通过主动监测与立即手术治疗低风险甲状腺乳头状微小癌过程中不良事件的发生率
Thyroid. 2016 Jan;26(1):150-5. doi: 10.1089/thy.2015.0313. Epub 2015 Nov 5.
6
Active Surveillance as First-Line Management of Papillary Microcarcinoma.主动监测作为甲状腺微小乳头状癌的一线治疗方法。
Annu Rev Med. 2019 Jan 27;70:369-379. doi: 10.1146/annurev-med-051517-125510. Epub 2018 Sep 19.
7
Effects of Pregnancy on Papillary Microcarcinomas of the Thyroid Re-Evaluated in the Entire Patient Series at Kuma Hospital.在熊本医院的所有患者系列中重新评估妊娠对甲状腺微小乳头状癌的影响。
Thyroid. 2016 Jan;26(1):156-60. doi: 10.1089/thy.2015.0393. Epub 2015 Dec 15.
8
Insights and clinical questions about the active surveillance of low-risk papillary thyroid microcarcinomas [Review].关于低风险甲状腺微小乳头状癌主动监测的见解与临床问题[综述]
Endocr J. 2016 Apr 25;63(4):323-8. doi: 10.1507/endocrj.EJ15-0637. Epub 2015 Dec 2.
9
Incidental and Non-incidental Papillary Thyroid Microcarcinoma in Denmark 1996-2015: A national study on incidence, outcome and thoughts on active surveillance.1996 - 2015年丹麦偶发性和非偶发性甲状腺微小乳头状癌:一项关于发病率、转归及主动监测思考的全国性研究
Cancer Epidemiol. 2019 Jun;60:46-50. doi: 10.1016/j.canep.2019.03.011. Epub 2019 Mar 23.
10
Active Surveillance Versus Immediate Surgery: Questionnaire Survey on the Current Treatment Strategy for Adult Patients with Low-Risk Papillary Thyroid Microcarcinoma in Japan.主动监测与即刻手术:日本低危型甲状腺微小乳头状癌成年患者当前治疗策略的问卷调查
Thyroid. 2019 Nov;29(11):1563-1571. doi: 10.1089/thy.2019.0211. Epub 2019 Sep 25.

引用本文的文献

1
Risk assessment of thyroid nodules with a multi-instance convolutional neural network.基于多实例卷积神经网络的甲状腺结节风险评估
Front Oncol. 2025 Jul 24;15:1608963. doi: 10.3389/fonc.2025.1608963. eCollection 2025.
2
Predictive nomogram for occult metastasis in central lymph nodes of papillary thyroid microcarcinoma based on clinical and ultrasound features.基于临床和超声特征的甲状腺微小乳头状癌中央区淋巴结隐匿性转移预测列线图
Gland Surg. 2025 Jul 31;14(7):1295-1305. doi: 10.21037/gs-2025-159. Epub 2025 Jul 28.
3
Regulatory SNP of TERT promoter accompanied by C228T and is an exacerbating factor of papillary thyroid carcinoma.
端粒酶逆转录酶(TERT)启动子伴随C228T的调控单核苷酸多态性是甲状腺乳头状癌的一个加重因素。
Oncol Lett. 2025 Apr 7;29(6):267. doi: 10.3892/ol.2025.15013. eCollection 2025 Jun.
4
Editorial: Papillary thyroid cancer: prognostic factors and risk assessment.社论:甲状腺乳头状癌:预后因素与风险评估
Front Endocrinol (Lausanne). 2025 Mar 3;16:1578271. doi: 10.3389/fendo.2025.1578271. eCollection 2025.
5
Influence of Tumor Laterality and Focality on Clinical Implications and Tumor Advancement in Well-Differentiated Thyroid Cancer.肿瘤侧别和灶性对分化型甲状腺癌临床意义及肿瘤进展的影响
Cancers (Basel). 2024 Dec 7;16(23):4109. doi: 10.3390/cancers16234109.
6
Central Neck Dissection in Papillary Thyroid Carcinoma: Benefits and Doubts in the Era of Thyroid Lobectomy.甲状腺乳头状癌的中央区颈淋巴结清扫术:甲状腺叶切除术时代的益处与疑问
Biomedicines. 2024 Sep 25;12(10):2177. doi: 10.3390/biomedicines12102177.
7
Survey of clinician perspective on management of papillary thyroid microcarcinoma in Australia and New Zealand.澳大利亚和新西兰临床医生对甲状腺微小乳头状癌管理的观点调查。
Gland Surg. 2024 Jun 30;13(6):784-793. doi: 10.21037/gs-24-25. Epub 2024 Jun 20.
8
Comprehensive Review of the Imaging Recommendations for Diagnosis, Staging, and Management of Thyroid Carcinoma.甲状腺癌诊断、分期及管理影像学建议的综合综述
J Clin Med. 2024 May 14;13(10):2904. doi: 10.3390/jcm13102904.
9
Clinicopathological Evaluation of Papillary Thyroid Microcarcinoma.甲状腺微小乳头状癌的临床病理评估
Cureus. 2024 Mar 18;16(3):e56404. doi: 10.7759/cureus.56404. eCollection 2024 Mar.
10
Papillary Thyroid Microcarcinoma: Differences between Lesions in Incidental and Nonincidental Settings-Considerations on These Clinical Entities and Personal Experience.甲状腺微小乳头状癌:偶然与非偶然发病情况下病变的差异——这些临床实体的考虑因素及个人经验。
Curr Oncol. 2024 Feb 6;31(2):941-951. doi: 10.3390/curroncol31020070.